Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.

Pediatr Nephrol · 2021 · PMC7701073 · PMID 32712761

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.070so close (0.05 < p ≤ 0.1)

The difference between treatments did not reach statistical significance due to the limited number of patients in this analysis ( p = 0.070).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.